Accessibility Menu
Sirona Biochem logo

Sirona Biochem(OTC) SRBCF

Current Price$0.01
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-92%
5 Year-97%
1 Year-72%
1 Month+509,900%
Sirona Biochem last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-21
Sirona Biochem stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+509,900%USD 0.002026-07-09
1 month+509,900%USD 0.002026-05-07
3 month+0%USD 0.012026-02-06
Year to date+0%USD 0.012025-12-17
1 year-71.82%USD 0.022025-07-09
3 year-93.63%USD 0.082023-07-18
5 year-97.02%USD 0.172021-07-21
Since inception-91.5%USD 0.062012-06-29

Sirona Biochem Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-CA$16.36K

Net Income (TTM)

-CA$2.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

139.39 (High)

Price

$0.01

Volume

1,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

Apr 22, 2026

SRBCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sirona Biochem

Sirona Biochem Corp. is a biotechnology company focused on developing and commercializing active ingredients for cosmetic and pharmaceutical applications. With a presence in Canada and France, the company is engaged in innovative projects, including a skin brightener and a diabetes treatment.

Products and Services
  • Development of a cosmetic skin brightener
  • Pharmaceutical solutions targeting diabetes
  • Research on anti-aging and antiviral compounds
Growth Outlook
  • Collaboration with ICGEB to develop antiviral compound library
  • Expansion into new markets for cosmetic products
  • Focus on innovative research to enhance product pipeline
Financial Highlights
  • Recent quarterly revenue of CAD 2,543, a decrease from previous quarters
  • Trailing twelve months (TTM) revenue of CAD 11,073, indicating fluctuating performance
  • Operating expenses reached CAD 658,160 in the latest quarter, reflecting ongoing investment in R&D
Sirona Biochem Corp. operates in a dynamic sector, focusing on the development of innovative solutions in biotechnology. The company has established a strong foundation with its ongoing projects and collaborations, particularly in the fields of cosmetics and pharmaceuticals. The partnership with the International Centre for Genetic Engineering and Biotechnology (ICGEB) highlights the commitment to advancing antiviral research, which could lead to significant breakthroughs in healthcare. Despite recent fluctuations in revenue, the company continues to invest heavily in research and development, which is crucial for long-term growth. The latest quarterly financials indicate a focus on expanding product offerings and market reach, positioning Sirona Biochem as a potential player in the biotechnology landscape. Investors may find the company's innovative approach and strategic collaborations appealing as it navigates the complexities of the biotechnology industry.
AI Generated • Jun 24, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Howard Jarman Verrico, MD

Website

www.sironabiochem.com

Headquarters

Vancouver, BC V7X 1L4, CA

SRBCF Financials

Key Financial Metrics (TTM)

Gross Margin

-82.71%

Operating Margin

-6917.60%

Net Income Margin

-7312.43%

Return on Equity

221.45%

Return on Capital

N/A

Return on Assets

-246.42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1.00K

Avg. Volume

822.758

Financials (TTM)

Gross Profit

-CA$23.76K

Operating Income

-CA$2.32M

EBITDA

-CA$2.30M

Operating Cash Flow

-CA$2.03M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$2.03M

Cash & ST Invst.

CA$33.62K

Total Debt

CA$3.32M

Sirona Biochem Performance Analysis

Sirona Biochem annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-10-31CAD 212,985N/A
20222022-10-31CAD 521,703144.9%
20232023-10-31CAD 25,785-95.1%
Sirona Biochem sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-10-31-562.9%
Q12024-01-31105.0%
Q22024-04-30604.8%
Q32024-07-31-77.0%
Sirona Biochem annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-10-31CAD -0.01N/A
20222022-10-31CAD -0.0143.8%
20232023-10-31CAD -0.01-34.8%
Sirona Biochem sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-10-31-19.0%
Q12024-01-31-16.0%
Q22024-04-3044.8%
Q32024-07-31-112.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

CA$2.54K

-62.7%

Gross Profit

CA$2.54K

-42.7%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

10

N/A

Net Income

-CA$885.18K

-68.4%

EBITDA

-CA$662.08K

-46.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

CA$33.62K

-89.1%

Total Debt

CA$3.32M

+100.0%

Accounts Receivable

CA$767.67K

+1705.4%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$1.78M

+13.9%

Short Term Debt

CA$1.54M

+1453.6%

Return on Assets

-2.46%

N/A

Return on Invested Capital

2.88%

N/A

Free Cash Flow

-CA$552.59K

-2.4%

Operating Cash Flow

-CA$552.59K

-2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMUCEOM Pharmaceuticals Holdings, Inc.
$0.25+90.77%
NYMXFNymox Pharmaceutical Corporation
$0.01+78.57%
LVCLFAlgorae Pharmaceuticals Limited
$0.01+0.00%
PPCBPropanc Biopharma, Inc.
$1.46+1.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.08-0.26%
TQQQProShares Trust - ProShares UltraPro Qqq
$66.13-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.37+0.06%
HBANHuntington Bancshares
$17.25-0.06%

Questions About SRBCF

What is the current price of Sirona Biochem?

Sirona Biochem is trading at $0.01 per share.

What is the 52-week range for Sirona Biochem?

Over the past 52 weeks, Sirona Biochem has traded between $0.01 and $0.02.

How much debt does Sirona Biochem have?

As of the most recent reporting period, Sirona Biochem reported total debt of CA$2.40M.

How much cash does Sirona Biochem have on hand?

Sirona Biochem reported CA$23.80K in cash and cash equivalents in its most recent financial results.

What is Sirona Biochem’s dividend yield?

Sirona Biochem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services